Unlike pharmaceutical sleep aids that cause next-day drowsiness, cognitive impairment, tolerance, and dependency, DSIP enhances sleep quality without sedative side effects, maintains normal sleep architecture, causes no morning grogginess, develops no tolerance requiring dose escalation, and demonstrates no withdrawal symptoms or addiction potential
FIGURE 1 TABLE 1 Pharmacokinetic parameters of BPC157 in rats following a single intravenous administration (mean SD, n = 6)
Third-party testing transparency Whether independent laboratory testing is provided, how accessible it is, and how clearly results are presented
Neuroprotective Effects Emerging studies suggest that Pentadecapeptide may offer neuroprotective benefits, potentially aiding in the treatment of conditions like traumatic brain injury and neurodegenerative diseases